SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062965
Filing Date
2023-11-13
Accepted
2023-11-13 16:15:18
Documents
13
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20231113.htm   iXBRL 8-K 50202
2 EX-99.1 drrx-ex99_1.htm EX-99.1 319419
  Complete submission text file 0000950170-23-062965.txt   507058

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20231113.xsd EX-101.SCH 2468
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20231113_lab.xml EX-101.LAB 17020
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20231113_pre.xml EX-101.PRE 10669
7 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20231113_htm.xml XML 4511
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 231398914
SIC: 2834 Pharmaceutical Preparations